These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 23240894)

  • 1. Portal, but not lobular, macrophages express matrix metalloproteinase-9: association with the ductular reaction and fibrosis in chronic hepatitis C.
    Gadd VL; Melino M; Roy S; Horsfall L; O'Rourke P; Williams MR; Irvine KM; Sweet MJ; Jonsson JR; Clouston AD; Powell EE
    Liver Int; 2013 Apr; 33(4):569-79. PubMed ID: 23240894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity of fibrosis patterns in non-alcoholic fatty liver disease supports the presence of multiple fibrogenic pathways.
    Skoien R; Richardson MM; Jonsson JR; Powell EE; Brunt EM; Neuschwander-Tetri BA; Bhathal PS; Dixon JB; O'Brien PE; Tilg H; Moschen AR; Baumann U; Brown RM; Couper RT; Manton ND; Ee LC; Weltman M; Clouston AD
    Liver Int; 2013 Apr; 33(4):624-32. PubMed ID: 23356584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrosis correlates with a ductular reaction in hepatitis C: roles of impaired replication, progenitor cells and steatosis.
    Clouston AD; Powell EE; Walsh MJ; Richardson MM; Demetris AJ; Jonsson JR
    Hepatology; 2005 Apr; 41(4):809-18. PubMed ID: 15793848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of functional gene polymorphisms of matrix metalloproteinase (MMP)-1, MMP-3 and MMP-9 with the progression of chronic liver disease.
    Okamoto K; Mimura K; Murawaki Y; Yuasa I
    J Gastroenterol Hepatol; 2005 Jul; 20(7):1102-8. PubMed ID: 15955221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix metalloproteinases 2 and 9 are markers of inflammation but not of the degree of fibrosis in chronic hepatitis C.
    Reif S; Somech R; Brazovski E; Reich R; Belson A; Konikoff FM; Kessler A
    Digestion; 2005; 71(2):124-30. PubMed ID: 15785038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The portal inflammatory infiltrate and ductular reaction in human nonalcoholic fatty liver disease.
    Gadd VL; Skoien R; Powell EE; Fagan KJ; Winterford C; Horsfall L; Irvine K; Clouston AD
    Hepatology; 2014 Apr; 59(4):1393-405. PubMed ID: 24254368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered pattern of circulating matrix metalloproteinases -2,- 9 and tissue inhibitor of metalloproteinase-2 in patients with HCV-related chronic hepatitis. Relationship to histological features.
    Bruno CM; Valenti M; Bertino G; Ardiri A; Consolo M; Mazzarino CM; Amoroso A; Neri S
    Panminerva Med; 2009 Dec; 51(4):191-6. PubMed ID: 20195229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble CD163, a macrophage activation marker, is independently associated with fibrosis in patients with chronic viral hepatitis B and C.
    Kazankov K; Barrera F; Møller HJ; Bibby BM; Vilstrup H; George J; Grønbaek H
    Hepatology; 2014 Aug; 60(2):521-30. PubMed ID: 24623375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosis.
    D'Ambrosio R; Aghemo A; Rumi MG; Ronchi G; Donato MF; Paradis V; Colombo M; Bedossa P
    Hepatology; 2012 Aug; 56(2):532-43. PubMed ID: 22271347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrahepatic lymphocyte phenotypes in hepatitis C virus infection: a comparison between cirrhotic and non-cirrhotic livers.
    Bonacini M; Govindarajan S; Kohla M; Lai MM; Lindsay KL
    Minerva Gastroenterol Dietol; 2007 Mar; 53(1):1-7. PubMed ID: 17415341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon gamma-secreting HCV-specific CD8+ T cells in the liver of patients with chronic C hepatitis: relation to liver fibrosis--ANRS HC EP07 study.
    Bonilla N; Barget N; Andrieu M; Roulot D; Letoumelin P; Grando V; Trinchet JC; Ganne-Carrié N; Beaugrand M; Deny P; Choppin J; Guillet J; Ziol M
    J Viral Hepat; 2006 Jul; 13(7):474-81. PubMed ID: 16792541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus (HCV) protein expression enhances hepatic fibrosis in HCV transgenic mice exposed to a fibrogenic agent.
    Chouteau P; Defer N; Florimond A; Caldéraro J; Higgs M; Gaudin A; Mérour E; Dhumeaux D; Lerat H; Pawlotsky JM
    J Hepatol; 2012 Sep; 57(3):499-507. PubMed ID: 22613003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant centrizonal features in chronic hepatic venous outflow obstruction: centrilobular mimicry of portal-based disease.
    Krings G; Can B; Ferrell L
    Am J Surg Pathol; 2014 Feb; 38(2):205-14. PubMed ID: 24418854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-invasive markers and predictors of severity of hepatic fibrosis in HCV patients at Sharkia Governorate, Egypt.
    el-Shorbagy E; Afefy AF; Ibrahem IA; Mangoud AM; Eissa MH; Sabee EI; Mahrous S; Abdel-Monem A; Ismail A; Morsy TA; Etewa S; Nor Edin E; Mostafa Y; Abouel-Magd Y; el-Sedawy M; Ragab H; el-Tokhy H; Hassan MI; Lakouz K; Abdel-Aziz K; el-Hady G; Saber M
    J Egypt Soc Parasitol; 2004 Apr; 34(1 Suppl):459-78. PubMed ID: 15124753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Participation of natural killer cells in the pathogenesis of bile duct lesions in biliary atresia.
    Okamura A; Harada K; Nio M; Nakanuma Y
    J Clin Pathol; 2013 Feb; 66(2):99-108. PubMed ID: 23162109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum cystatin C: a non-invasive marker of liver fibrosis or of current liver fibrogenesis in chronic hepatitis C? .
    Ladero JM; Cárdenas MC; Ortega L; González-Pino A; Cuenca F; Morales C; Lee-Brunner A
    Ann Hepatol; 2012; 11(5):648-51. PubMed ID: 22947524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toll-like receptor-4 expression by hepatic progenitor cells and biliary epithelial cells in HCV-related chronic liver disease.
    Vespasiani-Gentilucci U; Carotti S; Onetti-Muda A; Perrone G; Ginanni-Corradini S; Latasa MU; Avila MA; Carpino G; Picardi A; Morini S
    Mod Pathol; 2012 Apr; 25(4):576-89. PubMed ID: 22173288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of serum IgG, IgA and IgM levels as indicators of hepatic fibrosis in patients with chronic hepatitis C infection].
    Ortarık Z; Toyran A; Sen S; Mart Kömürcü SZ; Güvener E
    Mikrobiyol Bul; 2011 Apr; 45(2):296-305. PubMed ID: 21644073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential findings for CD14-positive hepatic monocytes/macrophages in primary biliary cirrhosis, chronic hepatitis C and nonalcoholic steatohepatitis.
    Leicester KL; Olynyk JK; Brunt EM; Britton RS; Bacon BR
    Liver Int; 2006 Jun; 26(5):559-65. PubMed ID: 16762000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical comparative study of fibrosis and biliary ductular reaction in alcoholic and viral chronic hepatitis.
    Egyed-Zsigmond I; Jung I; Egyed-Zsigmond I; Marton G; Gurzu S; Mezei T
    Rom J Morphol Embryol; 2010; 51(2):265-9. PubMed ID: 20495741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.